THE GEORGE INST FOR GLOBAL HEALTH has a total of 30 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Taiwan. Its main competitors in its focus markets pharmaceuticals are EB IP LYBRIDOS B V, DONG GUIYU and OCULAR TECH SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Taiwan | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Rodgers Anthony | 27 |
#2 | Macmahon Stephen | 19 |
#3 | Chow Clara | 11 |
#4 | Anthony Rodgers | 3 |
#5 | Stephen Macmahon | 2 |
#6 | Clara Chow | 1 |
Publication | Filing date | Title |
---|---|---|
TW202102208A | Low-dose triple combination formulation | |
AU2019309329A1 | Compositions for the treatment of hypertension | |
US2020306246A1 | Low-dose triple combination formulation | |
AU2018213147A1 | Compositions for the treatment of hypertension | |
US2018133227A1 | Compositions for the treatment of hypertension |